Mesothelin-targeted immunotherapies for malignant pleural mesothelioma
Jonathan Villena-Vargas, Prasad S. Adusumilli
Your comments are limited to 500 words. All accepted comments will be published online within 48 hours and
selected comments will be published in the print journal.
Your Comments
Mesothelin-targeted immunotherapies for malignant pleural mesothelioma